P504S: a new molecular marker for the detection of prostate carcinoma.
about
α-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissuesalpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiationQuantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurementsIdentification of androgen-coregulated protein networks from the microsomes of human prostate cancer cellsImmunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate CancerAlpha-methylacyl-CoA racemase from Mycobacterium tuberculosis. Mutational and structural characterization of the active site and the foldMolecular genetics of human prostate cancer.Deletion hotspots in AMACR promoter CpG island are cis-regulatory elements controlling the gene expression in the colon.Computer-aided detection of prostate cancer on tissue sectionsAMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.Current early diagnostic biomarkers of prostate cancerNKX3.1 as a marker of prostatic origin in metastatic tumors.Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer.α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCCDetection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor.Alpha-methylacyl-CoA racemase--an 'obscure' metabolic enzyme takes centre stage.Synthesis and use of isotope-labelled substrates for a mechanistic study on human alpha-methylacyl-CoA racemase 1A (AMACR; P504S).Defining aggressive prostate cancer using a 12-gene model.Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.Near-infrared fluorescent digital pathology for the automation of disease diagnosis and biomarker assessment.Dietary influences on tissue concentrations of phytanic acid and AMACR expression in the benign human prostate.Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes.Advantages and limitations of microarray technology in human cancer.Alpha-methylacyl CoA racemase (P504S): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies.Looking beyond morphology: cancer gene expression profiling using DNA microarrays.Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy.Benign mimickers of prostatic adenocarcinoma.α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up StudyNovel In Vivo model for combinatorial fluorescence labeling in mouse prostate.Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.Anti-glutamate receptor 2 as a new potential diagnostic probe for prostatic adenocarcinoma: a pilot immunohistochemical study.Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach.Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature.Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.Phytanic acid, AMACR and prostate cancer risk.Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer.Diagnosis of adenocarcinoma in prostate needle biopsy tissue.Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer.
P2860
Q24605772-4A7CDED4-7387-45FC-B563-A59ADAAAC017Q24669748-AC722F77-0A23-4496-BA76-3C17F8B1534FQ24673038-0DD4914C-69E8-426E-8923-9408BCA552C9Q24806811-5F7BC099-4FEC-4644-AA7B-05C0B7DFF2F4Q26767044-306DA38C-332F-4D72-A7A7-22F37406ED92Q28486954-17563049-A2AF-4678-AB02-F093683CBE9CQ31039228-7DBDD554-F07C-4BC3-9508-F41491E99903Q33400332-9FBB56FC-7E99-4F79-84FD-490D1CA7D88AQ33718744-2AC387CA-CD13-4C64-BD69-BE6D2195AE83Q33879432-CA3EA43C-4FD2-4669-9DA1-7C3B0C829790Q33922390-899B911D-3180-4829-8C36-D2B41DF0273DQ34123290-081D68FF-6A2A-426E-9A7F-B28737D6B1FEQ34314276-7DD1610E-FA16-467C-B78F-2E0B49264016Q34431168-A9447041-A8F5-40FC-AB24-775559571C05Q34680813-DCF0C1FA-F509-4A68-93E6-DCB0346C2934Q34750699-97CD4CB3-8150-45B2-84BF-C523CC18AC8EQ34925941-C2BC50B0-417F-41DA-9B0B-A49364332028Q35060298-42C80D4A-020A-4AAF-AB6E-98049A61D0D1Q35092050-64395509-0D33-4CBB-A54D-3665F4FDEBACQ35094651-545D8A1C-4D58-4E39-95CE-E974EA155B94Q35255004-A96C4D46-2933-4345-8D36-D461294EFD88Q35324499-8DC919A1-460E-433F-8DBC-B46AF9B72F0FQ35514392-C49FD453-A7B6-4909-B741-05A1752AB44DQ35551113-10E51625-0304-44D2-A573-67C02E905E77Q35596443-5F5FFCD2-B7F4-44A7-857C-5469194EFCF3Q35634835-0E28F575-9D42-4237-AA0C-917368253B88Q35636611-3512A1A5-3DD9-4723-90C6-686D61CDCA1BQ35672154-D6B066E0-95AC-4C00-8780-0627EB9149CCQ35703906-D5F9C2F1-C7C0-4C94-B931-1A7A1A1638EEQ35889257-A6645D0D-F083-4B4B-BBCF-1A39F0CE4B00Q35940184-630F9F5C-AB6F-4575-8372-A29D9E8E2A85Q36037264-ED2B7605-6838-40F3-A865-26F1CFE3EDF1Q36170386-A417FDDD-8E3A-4016-8268-4196398E3231Q36176427-F23E7017-6D56-4856-BCFC-0D78B92EF87EQ36329324-2F51A810-0528-4F18-AB64-269FE409D0C2Q36430735-5FB6567E-847B-4926-B086-0B8F2E3E6AB2Q36472442-5CA13E57-66A1-40BF-B37F-954AF4C4008BQ36703455-C085C46B-39C4-4620-BF9E-DA0C7EB983ACQ36734983-E1118102-B30D-4F13-9C1D-8CB15484CB48Q36858042-D8D5AF5E-54B1-4927-8094-7E643F5F23C4
P2860
P504S: a new molecular marker for the detection of prostate carcinoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
P504S: a new molecular marker for the detection of prostate carcinoma.
@ast
P504S: a new molecular marker for the detection of prostate carcinoma.
@en
type
label
P504S: a new molecular marker for the detection of prostate carcinoma.
@ast
P504S: a new molecular marker for the detection of prostate carcinoma.
@en
prefLabel
P504S: a new molecular marker for the detection of prostate carcinoma.
@ast
P504S: a new molecular marker for the detection of prostate carcinoma.
@en
P2093
P1476
P504S: a new molecular marker for the detection of prostate carcinoma.
@en
P2093
Babcook JS
Rathanaswami P
P304
P356
10.1097/00000478-200111000-00007
P407
P577
2001-11-01T00:00:00Z